comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 17:59:57 - browse：2611

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before.

The company’s mid-year operating profit jumped from 37.5 billion Danish kroner in 2022 to 48.9 billion Danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knudsen said during an August earnings call. The 30% growth rate came from sales of semaglutide, which Novo Nordisk sells for diabetes under the name Ozempic and for obesity as Wegovy.

With its new blockbuster drug in hand, Novo Nordisk is valued higher than the entire economy of Denmark, where it’s based.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： EpiPen alternative approval delay highlights citizen petition issue

knowledge

WSS

Ohio train derailment: Experts on toxic chemical risks

Biotech lab space demand falls sharply

Medicare Advantage isn’t working — for anyone

Microbiome research is starting to find links to chronic diseases

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

hotspot

comprehensive

focus

Hepatitis C has a cure — but many Americans still lack access to it

Virtual repurposing can help discover new uses for existing drugs

United colonoscopy coverage change 'may cost lives,' doctors say

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD podcast: possible new ALS drug, artificial wombs

Peter Hotez and the public health issue of online harassment

Senators: Long

State Dept. review finds Biden bears some blame for Afghanistan failures

NEJM study measures Covid brain fog, impact on IQ

focus

Childhood vaccination ad campaign launches in the U.K.

Biotech lab space demand falls sharply

FDA panel to weigh approval of NurOwn, controversial ALS drug

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

What Congress can do to address the rural doctor shortage

knowledge

focus

explore

Wikipedia